150 related articles for article (PubMed ID: 8485123)
1. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment.
de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
Arterioscler Thromb; 1993 May; 13(5):712-9. PubMed ID: 8485123
[TBL] [Abstract][Full Text] [Related]
2. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ
Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
[TBL] [Abstract][Full Text] [Related]
3. Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.
Lepage S; Nigon F; Bonnefont-Rousselot D; Assogba U; Goulinet S; Chancharme L; Delattre J; Bruckert E; Chapman MJ
J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):87-103. PubMed ID: 11150388
[TBL] [Abstract][Full Text] [Related]
4. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.
de Graaf J; Hak-Lemmers HL; Hectors MP; Demacker PN; Hendriks JC; Stalenhoef AF
Arterioscler Thromb; 1991; 11(2):298-306. PubMed ID: 1998647
[TBL] [Abstract][Full Text] [Related]
5. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
[TBL] [Abstract][Full Text] [Related]
6. Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients.
Dachet C; Cavallero E; Martin C; Girardot G; Jacotot B
Atherosclerosis; 1995 Feb; 113(1):1-9. PubMed ID: 7755644
[TBL] [Abstract][Full Text] [Related]
7. Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls.
de Graaf J; Swinkels DW; Demacker PN; de Haan AF; Stalenhoef AF
J Clin Endocrinol Metab; 1993 Jan; 76(1):197-202. PubMed ID: 8421088
[TBL] [Abstract][Full Text] [Related]
8. Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions.
Karabina SA; Liapikos TA; Grekas G; Goudevenos J; Tselepis AD
Biochim Biophys Acta; 1994 Jun; 1213(1):34-8. PubMed ID: 8011677
[TBL] [Abstract][Full Text] [Related]
9. Low density lipoprotein subfractions and [Ca2+]i in vascular smooth muscle cells.
Weisser B; Locher R; de Graaf J; Vetter W
Circ Res; 1993 Jul; 73(1):118-24. PubMed ID: 8508523
[TBL] [Abstract][Full Text] [Related]
10. Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia.
van Tits LJ; Smilde TJ; van Wissen S; de Graaf J; Kastelein JJ; Stalenhoef AF
J Investig Med; 2004 Apr; 52(3):177-84. PubMed ID: 15222407
[TBL] [Abstract][Full Text] [Related]
11. Differences in LDL receptor-mediated metabolism of three low density lipoprotein subfractions by human monocyte-derived macrophages: impact on the risk for atherosclerosis.
de Graaf J; Hendriks JC; Swinkels DW; Demacker PN; Stalenhoef AF
Artery; 1993; 20(4):201-30. PubMed ID: 8250739
[TBL] [Abstract][Full Text] [Related]
12. The effect of simvastatin treatment on the low-density lipoprotein subfraction profile and composition in familial hypercholesterolaemia.
de Graaf J; Demacker PN; Stalenhoef AF
Neth J Med; 1993 Dec; 43(5-6):254-61. PubMed ID: 8107933
[TBL] [Abstract][Full Text] [Related]
13. Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study.
Leonhardt W; Pfützner A; Müller J; Pietzsch J; Forst T; Karagiannis E; Lübben G; Hanefeld M
Atherosclerosis; 2008 Nov; 201(1):155-62. PubMed ID: 18374336
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of alpha-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles.
Garner B; Harvey DJ; Royle L; Frischmann M; Nigon F; Chapman MJ; Rudd PM
Glycobiology; 2001 Oct; 11(10):791-802. PubMed ID: 11588155
[TBL] [Abstract][Full Text] [Related]
15. Kinetic heterogeneity of low density lipoproteins in primary hypertriglyceridemia.
Vega GL; Grundy SM
Arteriosclerosis; 1986; 6(4):395-406. PubMed ID: 3729797
[TBL] [Abstract][Full Text] [Related]
16. Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Hatzikonstandinou HA; Mayroudi MC; Boudoulas H
Coron Artery Dis; 1996 Nov; 7(11):843-50. PubMed ID: 8993943
[TBL] [Abstract][Full Text] [Related]
17. LDL particle subclasses in hypercholesterolemia. Molecular determinants of reduced lipid hydroperoxide stability.
Chancharme L; Thérond P; Nigon F; Zarev S; Mallet A; Bruckert E; Chapman MJ
J Lipid Res; 2002 Mar; 43(3):453-62. PubMed ID: 11893782
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF
Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526
[TBL] [Abstract][Full Text] [Related]
19. Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control.
Sánchez-Quesada JL; Pérez A; Caixàs A; Ordónmez-Llanos J; Carreras G; Payés A; González-Sastre F; de Leiva A
Diabetologia; 1996 Dec; 39(12):1469-76. PubMed ID: 8960828
[TBL] [Abstract][Full Text] [Related]
20. Analytical capillary isotachophoresis of total plasma lipoproteins: a new tool to identify atherogenic low density lipoproteins.
Bittolo-Bon G; Cazzolato G
J Lipid Res; 1999 Jan; 40(1):170-7. PubMed ID: 9869664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
